Pharmacist-Based Strategy Places More Patients on Statins Pharmacist-Based Strategy Places More Patients on Statins
In two studies run in parallel, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing statin prescriptions for at-risk patients.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 16, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
Statins Reach More Patients With Pharmacist's Orders
(MedPage Today) -- PHILADELPHIA -- One way of looping remote pharmacists into the primary care clinician workflow successfully boosted statin initiation in the cluster-randomized SUPER LIPID trial.
Researchers devised an intervention of asynchronous... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 14, 2023 Category: American Health Source Type: news
Daily statins taken by millions could be replaced by remarkable new gene therapy that cuts 'bad' cholesterol by up to 50% with a SINGLE dose, scientists claim as they hail 'brave new world' of heart treatment
Daily statins taken by millions to ward off heart attacks and strokes could be replaced 'within the decade' by a gene-editing jab, scientists claim. (Source: the Mail online | Health)
Source: the Mail online | Health - November 12, 2023 Category: Consumer Health News Source Type: news
Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows
Popular weight loss drugs have dominated news headlines and social media, mostly for their ability to help people shed pounds and control diabetes. But now there is evidence that one of the drugs, semaglutide, can also help reduce the risk of dying from heart disease in some patients. The drug semaglutide is sold under the brand names Wegovy, Ozempic, and Rybelsus. This trial, however, only studied the effects of Wegovy, which is semaglutide at 2.4mg in injectable form, and currently approved for weight management. The results of a much-anticipated study, sponsored by semaglutide’s maker Novo Nordisk, investigating t...
Source: TIME: Health - November 11, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Another Study Ties Statins to T2D: Should Practice Change? Another Study Ties Statins to T2D: Should Practice Change?
The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 30, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Statin-associated autoimmune myopathy masquerading as recurrent falls in an older adult - Suppamutharwyam M, Shah TM.
Statins are widely prescribed in clinical practice. Statin-induced myopathy is relatively common, benign, and resolves after statin withdrawal. However, statin-associated autoimmune myopathy is an exceptionally rare and devastating complication that can oc... (Source: SafetyLit)
Source: SafetyLit - October 26, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Statin Could Fight Severe COVID, but Vitamin C Does Not: Study
WEDNESDAY, Oct. 25, 2023 -- Clinical trials investigating use of two widely available products -- vitamin C and the statin drug simvastatin -- in critically ill COVID patients have yielded far different results.
Simvastatin had a 96% likelihood of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 25, 2023 Category: General Medicine Source Type: news
Using Statins With Blood Thinners Linked With Less GI Bleeding Risk
(MedPage Today) -- VANCOUVER, British Columbia -- Patients taking blood thinners who were also prescribed statins had a lower risk of gastrointestinal bleeding, no matter what type of blood thinner was used, a retrospective analysis suggested... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
Oct 20 2023 This Week in Cardiology Oct 20 2023 This Week in Cardiology
Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 20, 2023 Category: Surgery Tags: Cardiology Commentary Source Type: news
Highly Potent Statin Stands Out for Diabetes, Cataract Risks
(MedPage Today) -- Two high-intensity statin regimens showed similar clinical efficacy when directly compared in secondary prevention, but one was associated with a greater risk of diabetes and cataracts in results from the LODESTAR trial.
Whether... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 19, 2023 Category: Cardiology Source Type: news
Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD
THURSDAY, Oct. 19, 2023 -- Rosuvastatin and atorvastatin have comparable efficacy for a composite outcome in adults with coronary artery disease, according to a study published online Oct. 18 in The BMJ.
Yong-Joon Lee, M.D., from the Yonsei... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 19, 2023 Category: Pharmaceuticals Source Type: news
Medication taken by millions of Britons could increase risk of diabetes, study warns
Taken by an estimated seven to eight million adults in the UK, statins are one of the most commonly prescribed drugs but one type could pose a diabetes risk. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2023 Category: Consumer Health News Source Type: news
Mayo Clinic Minute: Who benefits from taking statins?
If you're at risk of heart disease, your healthcare team might use the pooled cohort equation (PCE) tool to determine your long-term risk and whether taking statins — cholesterol-lowering medication — is a good option. Dr. Francisco Lopez-Jimenez, a Mayo Clinic cardiologist, says it's important to understand who benefits the most from statins. Watch: The Mayo Clinic Minute https://youtu.be/7J-pyvntHyg Journalists: Broadcast-quality video pkg (1:06) is in th e downloads at the end of the post. Please courtesy: "Mayo Clinic News Network." Read… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 3, 2023 Category: Databases & Libraries Source Type: news
DR ELLIE CANNON: Why is my cholesterol on the rise even when I'm taking my statins?
DR ELLIE CANNON: Today's reader is concerned that their cholesterol levels are increasing even though they are regularly taking the statins prescribed by their GP. (Source: the Mail online | Health)
Source: the Mail online | Health - September 30, 2023 Category: Consumer Health News Source Type: news
Warning of ‘rare but serious’ condition linked to statins - millions of Britons at risk
Almost 10 million people in the UK are thought to use cholesterol-busting statins. (Source: Daily Express - Health)
Source: Daily Express - Health - September 29, 2023 Category: Consumer Health News Source Type: news
